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Abstract
Since 2015, the number of hepatitis B virus (HBV) cases increased substantially in Germany.
In 2015, a more sensitive HBV case definition was introduced. This coincided with an asylum
seeker influx with differing screening strategies. Information on the asylum seeker status has
been collected since 09/2015. We investigated this increase to interpret HBV notification data
in Germany. We compared HBV surveillance data from 2010–2013 (baseline) with 2015–
2016, excluding 2014 due to beginning of asylum seeker influx. We estimated the excess
above the mean case number (baseline) using Poisson regression and compared asylum seeker
cases and the excess of cases with the unknown asylum seeker status. HBV cases increased
from 1855 (mean baseline) to 3873 (2015) and 3466 (2016) with 1903 asylum seeker cases
and 1099 excess-cases with the unknown asylum seeker status in 2015–2016. Cases only ful-
filling the changed case definition increased from 60% (1119) in baseline to 81% (P < 0.01) in
2015–2016; 69% of asylum seeker cases and 61% of excess-cases were males <40 years com-
pared to 27% (baseline) (P < 0.01). Changed case definition increased the number of cases in
official statistics substantially. Demographic and geographical distributions suggest that
screening of asylum seekers increased the case numbers even to a higher extent than surveil-
lance data indicates.
Introduction
Viral hepatitis is a major public health challenge. According to the World Health Organization
(WHO) an estimated 257 million people live worldwide with chronic hepatitis B [1].
Prevalence of active hepatitis B (hepatitis B surface antigen (HBsAg) positive) varies and is
highest in Sub-Saharan Africa and South Asia with 5–10% [2]. In Europe, the prevalence of
active hepatitis B is estimated to be 0.9%, corresponding to almost 4.7 million individuals liv-
ing with hepatitis B [3]. The incidence of active hepatitis B in European countries varies
between 0.1 and 23 per 100 000 inhabitants [4]. In Germany, vaccination against hepatitis B
is recommended for all children above the age of 2 months since 1995. In 2017, 86.9% of
all children were vaccinated as assessed during the school entry health examination [5].
Germany is a low prevalence country for hepatitis B and the last population-based survey
in the adult general population in Germany (DEGS1, 2008–2010) found a prevalence of active
hepatitis B of 0.3% [6].
Hepatitis B is a notifiable disease in Germany according to the Protection against Infection
Act (IfSG). According to the IfSG, hepatitis B cases are mandatorily to be notified from the
laboratory and the clinician to the LPHA irrespective of nationality or residence of the case.
In the period under investigation only acute hepatitis B infections were notifiable to LPHA
according to the IfSG.
In 2015, the case definition was changed to be more sensitive and to better comply with the
ECDC case definition [7]. According to the case definition before 2015 the presence of clinical
symptoms was necessary to constitute a case of hepatitis B, whereas according to the changed
case definition since 2015 cases have to fulfil laboratory criteria only.
As it could be difficult to discrimante acute and chronic infection for laboratories, we
believe that newly diagnosed hepatitis B virus (HBV) infections, irrespective of the infection
stage, were notified from the laboratory to the LPHA even before 2015. The case definition
is addressed to the LPHA and not to the laboratories. At LPHA cases are classified according
to the case definition, further investigations are conducted and prevention measures are imple-
mented [8]. Applying the case definition is supported by the notification software, but could
be decided manually. To apply the changed case definition, a software update was necessary in
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each LPHA. The LPHA enters the data into the notification soft-
ware including all important information, e.g. the asylum seeker
status or the most probable country of infection. All cases fulfill-
ing the laboratory criteria, irrespective of the clinical criteria, are
transmitted electronically from the LPHA to the state public
health authorities and from there further to the national public
health institute (Robert Koch Institute, RKI) [9]. Only cases ful-
filling the case definition are published nationally to inform sta-
keholders. According to the case definition before 2015 only
cases fulfilling also the clinical criteria were published in the sta-
tistics, whereas according to the changed case definition since
2015 all cases fulfilling the laboratory criteria are published.
Cases with an unknown infection stage (i.e. acute or chronic) fulfil
the case definition and are included in published data, but cases
that are known to be chronically infected in the notification
data are excluded from publication.
In 2015, Germany experienced a large influx of asylum seekers.
It is estimated that 890 000 asylum seekers came to Germany in
2015, mostly from Syria (36%), Albania (12%) and Kosovo
(8%) [10, 11]. In these countries, the prevalence of active hepatitis
B is higher than in Germany (5.6%, 9.5% and 2.4%, respectively)
[12–14]. Most asylum seekers were young males: 69% were male,
90% were below 40 years [11, 15, 16]. In 2015, three federal states
had included obligatory hepatitis B screening as part of their ini-
tial examination of asylum seekers [17–19]: Hamburg, Bavaria
and Saxony. Thuringia recommended a hepatitis B screening
only if indicated. Screening is implemented on a local level.
Data on screening implementation is not available at the national
level. Therefore, it is not known, to what extent these regulations
have been implemented. In Bavaria, threefold more asylum see-
kers were screened for hepatitis B in 2015 compared to 2014 [18].
Since 2015, a large increase of published hepatitis B cases has
been observed in Germany. We investigated to what extent this
increase is attributable to the changed case definition in 2015 or
the screening of asylum seekers to be able to better interpret noti-
fication data on hepatitis B in Germany.
Methods
Data and descriptive analyses
Data sources
We extracted and analysed all hepatitis B cases that were transmit-
ted to RKI irrespective of the case definition between 2010 and
2016 from the national surveillance database SurvNet with data
status as of 1 March 2017 [9].
Data on registered asylum seekers and refugees were obtained
from publications from the German Federal Office for Migration
and Refugees and the German Federal Agency for Civic
Education [11, 15, 16, 20].
Data analysis
As a first step, we performed a descriptive analysis by time-period
and federal state. Data from 2014 was excluded from the analyses,
because the influx of asylum seekers started during 2014, but infor-
mation on the asylum seeker status was not yet available in our noti-
fication data and the old case definition was still in place. We
analysed the data using Stata® version 14.1 and Microsoft Excel 2010.
Definitions
Each notification that has been transmitted to the RKI irrespective
of the applied case definition was defined as a case. Cases that
were transmitted as known chronic diseases were excluded from
the analysis.
Clinical criteria are not relevant for the case definition since
2015. From 2001 to 2016, also cases fulfilling only laboratory
criteria were transmitted to RKI.
Case definition before 2015
Cases fulfilling the case definition category
‘Clinical and Laboratory’: clinically and laboratory-confirmed
hepatitis B cases.
Until 2015, the case definition required clinical confirmation of
acute hepatitis and either direct (HBsAg or HBV-DNA) or indirect
(IgM-antibodies to hepatitis B core antigen (anti-HBc-IgM)) detec-
tion of the virus (clinically and laboratory-confirmed cases) (see
Table 1).
Case definition since 2015
Cases fulfilling the case definition categories
(1) ‘Clinical and Laboratory’: clinically and laboratory-confirmed
hepatitis B cases.
(2) ‘Laboratory without symptoms’: laboratory-confirmed hepa-
titis B cases without clinical hepatitis signs.
(3) ‘Laboratory only’: laboratory-confirmed hepatitis B cases
without information on clinical symptoms.
Since 1 January 2015, only direct detection of HBV fulfils the
laboratory criteria.
To apply the new case definition since 2015, a software update
was necessary in the LPHA. Those still using old versions applied
the old case definition. Case definitions are applied by the LPHA
only. If cases transmitted in 2015 and 2016 were categorised
according to the old case definition in place before 2015, the
RKI did not re-apply the changed case definition.
Asylum seeker cases
Since September 2015, detailed information on the asylum seeker
status has been collected in the surveillance system through a tick
box or free text in the comment field. This additional information
includes country of birth and date of arrival in Germany. Asylum
seeker cases were defined as hepatitis B cases that were labelled by
the LPHA as such in the notification data.
Cases with unknown asylum seeker status
For cases without information on the asylum seeker status it was
impossible to discriminate if these were non-asylum seekers (resi-
dents) or if the information was missing. Therefore, cases without
information were defined as cases with the unknown asylum
seeker status. These could include either non-asylum seekers (resi-
dents) or misclassified asylum seekers.
Most probable country of infection
The information on the most probable country of infection was
investigated by the LPHA and transmitted as additional informa-
tion in the notification software if available.
Implications of the changed case definition
The positive-predictive value (PPV) of the case definition was
defined by the proportion of transmitted hepatitis B cases that ful-
fil the case definition that was in place at the time when cases were
reported on all transmitted hepatitis B cases [21]. The PPV was
calculated per year of notification including cases according to
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the old and the changed case definition dependent on the soft-
ware used in the notifying LPHA. The PPV was also calculated
according to the case definition that was applied in the LPHA
at the time the case was reported. We compared proportions of
all transmitted cases by the case definition category in 2015 and
2016 to baseline (2010–2013).
Analysis of the hepatitis B cases identified through screening
of asylum seekers
The district and according federal state of a case was defined
by the LPHA that investigated and transmitted the case, in general
this is concordant with the address of the patient’s place of resi-
dence. Reporting incidence was calculated as the number of
cases per 100 000 inhabitants. Descriptive analysis by the asylum
seeker status, year of notification and district was performed.
Federal states with obligatory screening for hepatitis B in asylum
seekers were compared with federal states without regular screen-
ing. To determine if asylum seeker cases had acquired the infec-
tion in Germany or abroad we compared the most probable
country of infection, as defined by the LPHA, and year of entry
to Germany to the year of notification.
Analysis of the excess of hepatitis B cases with unknown asylum
seeker status in the years 2015 and 2016
Cases with the unknown asylum seeker status were analysed by
year of notification and compared to asylum seeker cases. As a
first step, we fitted a Poisson regression to the number of hepatitis
B cases between 2010 and 2013 stratified by the federal state, age
group (<40 years/≥40 years) and sex. We also checked a negative
binomial regression, but did not find a significantly improved fit
to the data. We assumed a constant baseline over time, since in
most federal states there was no significant secular trend, and in
the few federal states with an increasing or decreasing trend,
this trend seemed to be too instable to be extrapolated to future
years. Then we simulated the 95%-prediction interval from the
Poisson model. The number of excess cases was computed as
the number of observed cases above the prediction interval, i.e.
the positive part of the difference of the number of observed
cases and the upper bound of the prediction interval. This excess
number of cases was computed for the years 2015 and 2016 and –
to double check the quality of the model fit – for the time period
2010 to 2013. The age group and sex distribution was then com-
pared for excess cases and asylum seeker cases.
Implications of the changed case definition on the capture of
asylum seeker cases
To identify asylum seeker cases only captured because of the
changed case definition, we compared the proportion of asylum
seeker cases and cases with the unknown asylum seeker status
within case definition categories.
Statistics
To compare the proportions χ2 test was used.
The Wilcoxon–Mann–Whitney-test was used to compare
medians.
Results
The total number of transmitted cases to the RKI, irrespective if
the case definition was fulfilled, increased from a mean of 1855
cases per year in 2010–2013 to 3873 cases in 2015 and 3466 in
2016. This represents an absolute increase of 2018 cases in 2015
and 1611 cases in 2016.
Implications of the changed case definition
The PPV of transmitted cases fulfilling the case definition applied
by the LPHA increased substantially: in 2010–2013 40% of
transmitted cases (n = 736) on average fulfilled the case definition
which was applicable before 2015. In 2015, 51% (n = 1982) and in
2016, 87% (n = 3006) of transmitted cases fulfilled the case defin-
ition applied by the LPHA, either the case definition before or
since 2015 (see Fig. 1). In 2015, the software update to transmit
cases according to the changed case definition has not been
implemented in all LPHA: 62% of cases (n = 2392) were transmit-
ted according to the case definition which was applicable before
2015. This decreased in 2016 to 18% of cases (n = 629). The
PPV of cases fulfilling the case definition which was in place
before 2015 was 34%, of cases fulfilling the case definition since
2015 100% (P-value <0.01).
Cases transmitted in the categories that only fulfil the case
definition since 2015 (‘Laboratory without symptoms’ and
‘Laboratory only’) increased significantly from a mean of 60%
(n = 1119) in baseline (2010–2013) to 81% in 2015 (n = 3139)
and 80% in 2016 (n = 2783) (P < 0.01). The number of cases
with clinical information and transmitted within the categories
‘Clinical and Laboratory’ and ‘Laboratory without symptoms’
did not substantially increase since 2015. The observed increase
Table 1. Summary of hepatitis B case definitions in Germany before and since
2015
Before 2015 Since 2015
Laboratory criteria Direct or indirect
detection of HBV:
• HBV-DNA
• confirmed HBs-Ag
• anti-HBc-IgM
Direct detection of HBV:
• HBV-DNA
• confirmed HBs-Ag
Clinical criteria Clinical signs of acute
hepatitis
Not relevant
Case definition ‘Clinical and
Laboratory’:
• clinically and
laboratory-confirmed
hepatitis B cases
‘Clinical and Laboratory’:
• clinically and
laboratory-confirmed
hepatitis B cases
‘Laboratory without
symptoms’:
- laboratory-confirmed
hepatitis B cases
without clinical
confirmation
‘Laboratory only’:
• laboratory-confirmed
hepatitis B cases
without information on
clinical symptoms
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of transmitted cases since 2015 is only attributable to cases within
category ‘Laboratory only’ for which no clinical information
is available at LPHA: from a mean of 252 cases in baseline
(2010–2013) cases increased by 2296 in 2015 and by 1888 in
2016 (P < 0.01).
Hepatitis B cases identified through screening of asylum
seekers
In 2015, 869 (22%) of all transmitted hepatitis B cases were
known asylum seekers. This increased in 2016 to 1034 (30%)
cases. The increase of transmitted cases started in 2015 before
information on asylum seekers was available in the surveillance
system (second half of 2015, see Fig. 2). The increase of cases
in the surveillance system was observed in the same time period
as the increase in registered asylum seekers in Germany.
Reporting incidence of hepatitis B cases varied in different
federal states over time (see Table 2). In few federal states case
numbers remained unaffected in 2015 and 2016 compared to
baseline (e.g. Thuringia), whereas in most federal states case num-
bers increased in 2015 compared to baseline (e.g. Hamburg,
Bavaria). Only in one federal state, the reporting incidence
declined in both, 2015 and 2016, compared to baseline
(Bremen).
According to information on the surveillance data, 98% of asy-
lum seeker cases in 2015 and 66% in 2016 had entered Germany
in the same year their hepatitis B infection was notified. Of 422
asylum seeker cases (22%) in 2015–2016 with information on
Fig. 1. Number of transmitted hepatitis B cases according to case definition, case definition category and year of notification during the transition phase of imple-
mentation of the new case definition since 2015, Germany 2010–2016. * Cases published in official statistics.
Fig. 2. Number of transmitted hepatitis B cases in 2010–2016 according to the asylum seeker status and the number of registered asylum seekers in Germany in
2015–2016 per quarter (due to the time delay in processing applications for asylum, asylum seekers were registered on arrival in Germany [15, 16, 20]).
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probable country of infection, in 50 cases (12%) Germany was
reported as probable country of infection.
Excess of hepatitis B cases with unknown asylum seeker status
in the years 2015 and 2016
In 2015 and 2016, asylum seeker cases were younger than cases
with the unknown asylum seeker status (median age 25 vs. 37
years, P < 0.01) and more likely to be male (80% vs. 63%, P <
0.01). Cases with the unknown asylum seeker status differed in
2015 and 2016 to cases in 2010–2013 (baseline): In 2015, cases
with the unknown asylum seeker status were younger than
those in 2010–2013 (median age 36 vs. 41 years, P < 0.01) and
more often male (65% vs. 62%, P < 0.01). In 2016, cases with
the unknown asylum seeker status were younger than in baseline
(median age 39 vs. 41 years, P < 0.01).
The excess of cases with the unknown asylum seeker status was
calculated to be 766 cases in 2015 and 333 cases in 2016 (see
Fig. 3). Overall, the excess of cases with the unknown asylum
seeker status consisted mainly of male cases younger than
40 years. Whereas in 2010–2013, 20% of cases were males
younger than 40 years, this was higher in asylum seeker cases
(69%, P < 0.01). The excess of cases with the unknown asylum
seeker status was similar to asylum seeker cases in 2015 (68%
males <40 years, n = 520 cases, P = 0.4), but in 2016 the excess
of cases with the unknown asylum seeker status was different
from asylum seeker cases (45% males <40 years, n = 151 cases,
P < 0.01) (see Table 3).
Implications of the changed case definition on the capture of
asylum seeker cases
Asylum seeker cases in 2015 and 2016 were mostly transmitted
according to the changed case definition: 1759 asylum seeker
cases (92%) were transmitted within the case definition categories
‘Laboratory without symptoms’ and ‘Laboratory only’, compared
to 4163 cases with the unknown asylum seeker status (77%).
Asylum seeker cases were significantly more likely to be transmit-
ted within case definition categories without clinical information
(P < 0.01).
Discussion
The increase of hepatitis B cases published in official statistics in
Germany has been partly caused by the change in case definition
in 2015. The change in the case definition was important to
include all active hepatitis B cases in the surveillance system,
regardless of the information on clinical symptoms. Cases without
information on clinical symptoms were already transmitted to the
national level before 2015, but were not published as they did not
fulfil the case definition by then. Therefore, the more sensitive
case definition since 2015 led to an expected increase in the
Table 2. Number of transmitted hepatitis B cases/100▫000 inhabitants for each federal state in 2010–2013, 2015 and 2016 according to the asylum seeker status, and
difference in reporting incidence (total) Germany
Hepatitis B reporting incidence
Difference to
baseline
Federal state
Mean 2010–2013
(baseline)
2015 2016
2015 2016
Total Total
Asylum seeker
cases (%) Total
Asylum seeker
cases (%) Total Total
Hamburg a 2.9 36.3 64 8.9 61 +33.4 +6.0
Bavaria a 2.6 8.2 27 7.2 48 +5.6 +4.6
Saxony a 3.7 6.5 14 8.0 35 +2.7 +4.3
Hesse 3.3 6.1 7 6.3 16 +2.8 +3.0
Schleswig-Holstein 1.9 4.5 1 3.7 8 +2.6 +1.8
Mecklenburg-Western Pomerania 0.9 2.2 5 2.9 14 +1.3 +2.0
Baden-Wurttemberg 1.9 3.0 5 3.5 23 +1.1 +1.6
Saxony-Anhalt 2.0 3.3 21 3.2 48 +1.4 +1.2
Brandenburg 1.7 2.4 15 3.2 30 +0.8 +1.6
Rhineland-Palatinate 2.9 2.4 11 4.7 20 −0.6 +1.8
Lower Saxony 1.1 1.7 36 1.7 51 +0.6 +0.6
North Rhine-Westphalia 1.5 2.1 5 2.0 10 +0.6 +0.4
Berlin 6.6 7.0 6 6.7 15 +0.3 +0.1
Thuringia 0.7 0.9 5 0.7 38 +0.2 +0.0
Saarland 3.2 3.3 0 2.1 0 +0.1 −1.1
Bremen 2.4 0.7 0 1.3 22 −1.6 −1.1
Total 2.3 4.7 22 4.2 30 +2.5 +2.0
aFederal states that conducted hepatitis B screening in asylum seekers in 2015 [17–19, 22].
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number of published cases, but did not affect the overall number
of transmitted cases. Classification of cases according to the case
definition depends on the software used. A software update,
which was necessary to transmit cases according to the changed
case definition, has been implemented stepwise in the LPHA.
During 2015 and 2016, at the same time some LPHA applied the
old and others the changed case definition. As the PPV of the chan-
ged case definition since 2015 was significantly higher and the pro-
portion of LPHA applying the old case definition decreased over
time, this lead to an increase in published case numbers.
Therefore, the time of implementation in each LPHA influenced
the number of transmitted cases fulfilling the case definition and
had an impact on the number of published cases. We believe
that the changed laboratory criteria in 2015 had only a minor effect
on the number of notified cases, but the actual impact of this
remains unknown and should be investigated further.
Nevertheless, the number of transmitted cases without clinical
information has increased since the change in case definition in
2015 leading to poorer data quality.
A substantial increase in the number of transmitted cases was
due to the large influx of asylum seekers originating mostly from
high prevalence countries for hepatitis B into Germany, and hepa-
titis B screening activities within this population. A study con-
ducted in a reception centre for immigrants in Northern
Germany found a prevalence of active hepatitis B of 2.3% [23].
This is in accordance with screening results obtained in Bavaria,
where 3.3% of asylum seekers were diagnosed with active hepatitis
B [18]. The increase in the number of cases varied between federal
states and districts. Regulations on screening practices for asylum
seekers alone cannot explain the increase in all federal states as
also federal states without such a regulation observed an increase
in reporting incidence of hepatitis B. In federal states with the
highest increase in reporting incidence (Hamburg, Bavaria and
Saxony), hepatitis B screening was conducted for all asylum see-
kers. How screening regulations have been put into practice on
the district level and if federal states without such a regulation
performed a systematic screening for hepatitis B in asylum seekers
remains unclear. A study conducted from June to October 2015 in
four federal states found that 14 of 33 surveyed local public health
authorities screened all asylum seekers for hepatitis B, whereas 13
screened only a subset (including symptomatic individuals) and 6
did not perform a screening [22]. In 2015, the incidence of
chronic hepatitis B cases has risen in European countries accord-
ing to ECDC due to increased local testing among migrants and
other key populations [4] as migrants in European countries
account for 25% of all chronic hepatitis B cases [24]. This is
also supported by the finding that the highest increase of hepatitis
B reporting incidence in 2015 compared to 2010–2013 was found
mostly in countries that also recorded the highest number of
registered asylum seekers compared with the population in this
Fig. 3. Summary of expected number of cases in 2015–2016 with 95% prediction interval (PI) and real observed number of cases according to the asylum seeker
status, Germany 2010–2016.
Table 3. Comparison of demographics of excess cases with the unknown
asylum seeker status, Germany 2010-2016.
Sex
Age
group
(in
years)
2010–2013
n (%) 2015 n (%) 2016 n (%)
Male Total 14 (41%) 596 (78%) 208 (62%)
<40 11 (32%) 520 (68%) 151 (45%)
≥40 3 (9%) 76 (10%) 57 (17%)
Female Total 20 (59%) 170 (22%) 125 (38%)
<40 8 (24%) 123 (16%) 89 (27%)
≥40 12 (35%) 47 (6%) 36 (11%)
Total Total 34 (100%) 766 (100%) 333 (100%)
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year (such as Sweden, Austria, Finland and Germany) [25]. The
incidence of hepatitis B should be interpreted carefully because it
is an under-diagnosed chronic disease. Epidemiology of other
infectious diseases was impacted by the influx and screening of asy-
lum seekers, too [26]. Referral of asylum seekers from one district
or federal state to another might have led to double registration and
potentially double screening for hepatitis B and, therefore, might
have increased the number of transmitted cases. It might also
have led to incorrect allocation of cases to federal states.
The majority of hepatitis B infections in asylum seeker cases was
imported from abroad and not acquired in Germany, which is not
surprising considering that most of them came from countries with
high prevalence [12–14]. However, interpretation of this informa-
tion is difficult because of poor data quality as the information on
the probable country of infection was only available for a subset
of cases and as this information was determined by the LPHAwith-
out further information on the criteria applied. Interpretation of this
information is especially aggravated in chronic infectious diseases.
In other European countries hepatitis B infection was imported
for 61% of reported cases in 2015 [4].
Screening of asylum seekers might have influenced the number
of hepatitis B cases even to a higher extent than the notification
data indicates. Changes in age and sex distribution amongst
cases with the unknown asylum seeker status before and after
2014 suggest that, in reality, many asylum seekers might be
amongst the cases with the unknown asylum seeker status, espe-
cially in 2015. This is supported by our results on the excess of
cases with the unknown asylum seeker status, although our
model might even underestimate the excess. Collection of infor-
mation on the asylum seeker status has been implemented in
the surveillance system in late 2015 and the necessary software
update has been implemented in LPHA only stepwise afterwards.
In addition, difficulties in case investigation in asylum seeker
cases due to language barriers or relocation might have contribu-
ted to more unknown information (e.g. clinical information, probable
country of infection) in these cases. This could explain why asylum
seeker cases are more often transmitted without clinical information
(category ‘Laboratory only’). Without the change in case definition all
these cases would not have been published as they did not fulfil the
case definition before 2015. Information on true numbers and demo-
graphics of asylum seekers coming to Germany is scarce and comes
with a large time delay, especially in 2015.
According to the Protection against Infection Act only acute
hepatitis B infections were notifiable to LPHA until 2017. We
believe that laboratories notified all newly diagnosed hepatitis B
cases, irrespective of their infection stage, even before the adap-
tion of the law as it is difficult to discriminate infection stages
on the basis of laboratory findings only and the notification
data contains also cases with unknown stage and known chronic
infections. Since 2017 all active hepatitis B cases are notifiable in
Germany. This revised Act also emphasised the need to improve
the quality of surveillance data regarding country of birth and
whether an infection is considered to be imported as ECDC
recommends [4]. Based on our analysis we revised analysis, dis-
play and publishing of hepatitis B surveillance data, e.g. within
the annual report on infectious diseases [27].
Conclusion
The change in case definition increased the number of hepatitis B
cases published in official statistics substantially. Influx and
screening of asylum seekers increased the number of transmitted
cases even to a higher extent than the surveillance data indicates.
The epidemiology of hepatitis B in Germany might have changed
due to the influx of asylum seekers from countries with high
prevalence. The change in case definition was essential to publish
all cases with active hepatitis B including cases with limited or
missing clinical information. Especially, asylum seeker cases
would not have been captured in published data without the
change in case definition.
Recommendation
Information on the asylum seeker status is valuable and complete-
ness should be improved. One step towards this has been taken by
adding country of birth and year of entry to Germany as manda-
tory information in the revised Protection against Infection Act in
2017. To better understand the impact of the influx of asylum see-
kers on the epidemiology of infectious diseases in Germany, sur-
veillance data should be followed up in the next years and reliable
information on screening practices within federal states and dis-
tricts should be made available. To support the health of asylum
seekers and prevent the increased spread of hepatitis B in
Germany health assessment immediately after arrival, universal
vaccination of infants and children against hepatitis B and vaccin-
ation based on other indications according to the Standing
Committee on Vaccination recommendations should be ensured.
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